131 related articles for article (PubMed ID: 33417923)
21. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
[TBL] [Abstract][Full Text] [Related]
22. The transcription factor c-Jun regulates Smad4 expression by upregulating pre-miR-183 expression to promote invasion and metastasis of esophageal squamous cell carcinomas.
Xu X; Zheng L; Hang N; Zhu G; Mao W; Fan Y; Tao K
In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):550-558. PubMed ID: 32886291
[TBL] [Abstract][Full Text] [Related]
23. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract][Full Text] [Related]
24. SSRP1 Worsens Malignant Melanoma Progression by Activating MAPKs Pathway.
Yu Y; Gao Y; Yu Y
Ann Clin Lab Sci; 2021 Nov; 51(6):783-789. PubMed ID: 34921031
[TBL] [Abstract][Full Text] [Related]
25. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.
Xu Y; Sun W; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Chen Y
Exp Cell Res; 2019 Jun; 379(1):48-54. PubMed ID: 30880030
[TBL] [Abstract][Full Text] [Related]
26. NAV2 facilitates invasion of cutaneous melanoma cells by targeting SNAI2 through the GSK-3β/β-catenin pathway.
Hu W; Li X; Cheng R; Ke J; Liu Y; Ma M; Cao Y; Liu D
Arch Dermatol Res; 2019 Jul; 311(5):399-410. PubMed ID: 30997569
[TBL] [Abstract][Full Text] [Related]
27. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation.
Zhang L; Shan X; Chen Q; Xu D; Fan X; Yu M; Yan Q; Liu J
J Cell Physiol; 2019 Dec; 234(12):22207-22219. PubMed ID: 31192452
[TBL] [Abstract][Full Text] [Related]
29. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
Ding X; Li F; Zhang L
Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].
Tsai HE; Wu JC; Kung ML; Liu LF; Kuo LH; Kuo HM; Chen SC; Chan EC; Wu CS; Tai MH; Liu GS
PLoS One; 2013; 8(3):e59345. PubMed ID: 23536873
[TBL] [Abstract][Full Text] [Related]
32. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
33. C-Jun drives melanoma progression in PTEN wild type melanoma cells.
Kappelmann-Fenzl M; Gebhard C; Matthies AO; Kuphal S; Rehli M; Bosserhoff AK
Cell Death Dis; 2019 Aug; 10(8):584. PubMed ID: 31378787
[TBL] [Abstract][Full Text] [Related]
34. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
Yang F; Li S; Cheng Y; Li J; Han X
Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
[TBL] [Abstract][Full Text] [Related]
35. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
36. Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma.
Spangler B; Vardimon L; Bosserhoff AK; Kuphal S
Pigment Cell Melanoma Res; 2011 Feb; 24(1):148-64. PubMed ID: 20977688
[TBL] [Abstract][Full Text] [Related]
37. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
38. Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.
Venza I; Visalli M; Oteri R; Cucinotta M; Teti D; Venza M
Pigment Cell Melanoma Res; 2013 Mar; 26(2):193-204. PubMed ID: 23176534
[TBL] [Abstract][Full Text] [Related]
39. AFF4 regulates cellular adipogenic differentiation via targeting autophagy.
Chen Y; Li Q; Liu Y; Chen X; Jiang S; Lin W; Zhang Y; Liu R; Shao B; Chen C; Yuan Q; Zhou C
PLoS Genet; 2022 Sep; 18(9):e1010425. PubMed ID: 36149892
[TBL] [Abstract][Full Text] [Related]
40. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
